[1. Eftekharian A, Roozbahany NA, Vaezeafshar R, Narimani N. Deep neck infections: a retrospective review of 112 cases. Eur Arch Otorhinolaryngol. 2009; 266(2): 273-277.10.1007/s00405-008-0734-518553093]Search in Google Scholar
[2. Vieira F, Allen SM, Stocks RM, Thompson JW. Deep neck infections. Otolaryngol Clin North Am. 2008; 41(3): 459-483.10.1016/j.otc.2008.01.00218435993]Search in Google Scholar
[3. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003; 10(1): 45-65.10.1038/sj.cdd.440118912655295]Search in Google Scholar
[4. Petković AB, Matić SM, Stamatović NV, Vojvodić DV, Todorović TM, Lazić ZR et al. Proinflammatory cytokines (IL-1b and TNF-a) and chemokines (IL-8 and MIP-1a) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg. 2010; 39(5): 478-485.10.1016/j.ijom.2010.01.01420207110]Search in Google Scholar
[5. Wiercińska-Drapalo A, Flisiak R, Jaroszewicz J, Prokopowicz D. Increased plasma transforming growth factor-b1 is associated with disease progression in HIV-1-infected patients. Viral Immunol. 2004; 17(1): 109-113.10.1089/08828240432287550215018667]Search in Google Scholar
[6. McCartney-Francis NL, Wahl SM. Transforming growth factor b: a matter of life and death. J Leukoc Biol. 1994; 55(3): 401-409.10.1002/jlb.55.3.4018120457]Search in Google Scholar
[7. Skorpil N, Kolesár L, Striz I, Lardy NM, Slavcev A. Cytokine gene polymorphisms in the Dutch population. Int J Immunogenet. 2007; 34(2): 87-90.10.1111/j.1744-313X.2007.00663.x17373932]Search in Google Scholar
[8. Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA. Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immun. 2001; 2(5): 280-283.10.1038/sj.gene.636377111528523]Search in Google Scholar
[9. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leuk Biol. 1999; 66(4): 562-566.10.1002/jlb.66.4.56210534109]Search in Google Scholar
[10. Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997; 94(7): 3195-3199.10.1073/pnas.94.7.3195203459096369]Search in Google Scholar
[11. Peng Z, Zhan L, Chen S, Xu E. Association of transforming growth factor-b1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study. Lipids Health Dis. 2011; 10(1): 100-107.10.1186/1476-511X-10-100312958021679448]Search in Google Scholar
[12. Huang TT, Liu TC, Chen PR, Tseng FY, Yeh TH, Chen YS. Deep neck infection: analysis of 185 cases. Head Neck. 2004; 26(10): 854-860.10.1002/hed.2001415390207]Search in Google Scholar
[13. Moreira PR, Costa JE, Gomez RS, Gollob KJ, Dutra WO. TNFA and IL10 gene polymorphisms are not associated with periodontitis in Brazilians. Open Dent J. 2009; 3: 184-190.10.2174/1874210600903010184274556519771178]Search in Google Scholar
[14. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality. JAMA. 1999; 282(6): 561-568.10.1001/jama.282.6.56110450718]Search in Google Scholar
[15. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature. 1994; 371(6497): 508-510.10.1038/371508a07935762]Search in Google Scholar
[16. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-a gene promoter region may be associated with death from meningococcal disease. J Infect Dis. 1996; 174(4): 878-880.10.1093/infdis/174.4.8788843235]Search in Google Scholar
[17. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 1995; 182(5): 1259-1264.10.1084/jem.182.5.125921921987595196]Search in Google Scholar
[18. Lee YH, Ji JD, Song GG. Tumor necrosis factora promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol. 2007; 34(1): 43-49.]Search in Google Scholar
[19. Suh KI, Kim YK, Kho HS. Salivary levels of IL-1b, IL-6, IL-8, and TNF-a in patients with burning mouth syndrome. Arch Oral Biol. 2009; 54(9): 797-802.10.1016/j.archoralbio.2009.05.00719555923]Search in Google Scholar
[20. Guimarães AL, Correia-Silva Jde F, Sá AR, Victória JM, Diniz MG, Costa Fde O, et al. Investigation of functional gene polymorphisms IL-1b, IL-6, IL-10 and TNF-a in individuals with recurrent aphthous stomatitis. Arch Oral Biol. 2007; 52(3): 268-272.10.1016/j.archoralbio.2006.08.00817052682]Search in Google Scholar
[21. Rani HS, Madhavi G, Srikanth BMV, Jharna P, Rao URK, Jyothy A. Serum ADA and C-reactive protein in rheumatoid arthritis. Int J Hum Genet. 2006; 6(3): 195-198.10.1080/09723757.2006.11885963]Search in Google Scholar
[22. Lakka HM, Lakka TA, Rankinen T, Rice T, Rao DC, Leon AS, et al. The TNF-a G-308A poly levels: the HERITAGE Family Study. Vascul Pharmacol. 2006; 44(5): 377-383.10.1016/j.vph.2006.02.00216581306]Search in Google Scholar
[23. Jevtovic-Stoimenov T, Kocic G, Pavlovic D, Macukanovic-Golubovic L, Marjanovic G, Djordjevic V, et al. Polymorphisms of tumornecrosis factor-a -308 and lymphotoxin-a +250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non- Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008; 49(11): 2163-2169.10.1080/1042819080238122019021060]Search in Google Scholar
[24. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-b1 gene results in mul-tifocal inflammatory disease. Nature. 1992; 359(6397): 693-699.10.1038/359693a038891661436033]Search in Google Scholar
[25. Lu SL, Reh D, Li AG, Woods J, Corless CL, Kulesz-Martin M, et al. Overexpression of transforming growth factor b1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperprolifera-tion. Cancer Res. 2004; 64(13): 4405-441010.1158/0008-5472.CAN-04-103215231647]Search in Google Scholar
[26. Ueda T, Niimi A, Matsumoto H, Takemura M, Yamaguchi M, Matsuo Ka H. et al. TGFb1 promoter polymorphism C-509T and pathophysiology of asthma. J Allergy Clin Immunol. 200; 121(3): 659-664.10.1016/j.jaci.2007.10.00518036644]Search in Google Scholar
[27. Zhang L, Chang WW, Ding H, Su H, Wang HY. Transforming growth factor-b1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Int J Tuberc Lung Dis. 2011; 15(10): 1301-1307.10.5588/ijtld.10.029521740629]Search in Google Scholar
[28. Niu H, Niu Z, Zhang XL, Chen ZL. Absence of association between transforming growth factor b1 polymorphisms and gastric cancer: a metaanalysis. DNA Cell Biol. 2012; 31(5): 706-712.10.1089/dna.2011.142622074128]Search in Google Scholar
[29. Xiang TX, Cheng N, Li XN, Wu XP. Association between transforming growth factor-b1 polymorphisms and hepatocellular cancer risk: a meta- analysis. Hepatol Re. 2012; 42(6): 583-590.10.1111/j.1872-034X.2011.00958.x22257092]Search in Google Scholar
[30. de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB, Line SR. Analysis of the TGFb1 promoter polymorphism (C-509T) in patients with chronic periodon-titis. J Clin Periodontol. 2003; 30(6): 519-523.10.1034/j.1600-051X.2003.00323.x]Search in Google Scholar
[31. Holla LI, Fassmann A, Benes P, Halabala T, Znojil V. 5 Polymorphisms in the transforming growth factor-b1 gene (TGF-b1) in adult periodontitis. J Clin Periodontol. 2002; 29(4): 336-341. 10.1034/j.1600-051X.2002.290409.x]Search in Google Scholar